Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-21 Purchase | 2024-05-23 4:33 pm | Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director | 15,000 | $16.98 | $254,700 | 76,330 (Direct) | View |
| 2024-03-08 Purchase | 2024-03-12 4:32 pm | Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director | 15,000 | $16.3 | $244,500 | 61,330 (Direct) | View |
| 2022-08-02 Sale | 2022-08-03 4:44 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 837 | $69.66 | $58,305 | 551,176 (Direct) | View |
| 2022-03-08 Sale | 2022-03-09 4:48 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 2,385 | $70.1 | $167,189 | 552,013 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 5:01 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 995 | $149.38 | $148,631 | 554,398 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 6:29 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 95,000 | $199.55 | $18,957,452 | 555,393 (Direct) | View |
| 2021-04-01 Sale | 2021-04-02 4:14 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 7,928 | $134.12 | $1,063,303 | 650,393 (Direct) | View |
| 2020-07-31 Sale | 2020-08-03 5:51 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 896 | $76.39 | $68,444 | 649,062 (Direct) | View |
| 2020-05-11 Sale | 2020-05-12 4:13 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 31,332 | $63.73 | $1,996,726 | 649,958 (Direct) | View |
| 2020-05-07 Sale | 2020-05-11 4:17 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 62,896 | $64.11 | $4,032,390 | 740,057 (Direct) | View |
| 2020-05-05 Sale | 2020-05-07 4:41 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 60,164 | $63.36 | $3,812,170 | 920,489 (Direct) | View |
| 2020-02-28 Sale | 2020-03-02 5:13 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 3,893 | $72.22 | $281,133 | 524,090 (Direct) | View |
| 2020-01-17 Sale | 2020-01-22 4:19 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 133,777 | $95 | $12,708,815 | 509,465 (Direct) | View |
| 2019-11-25 Sale | 2019-11-26 4:29 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 16,223 | $96.04 | $1,558,057 | 643,242 (Direct) | View |
| 2019-11-20 Sale | 2019-11-22 4:22 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 150,000 | $90.36 | $13,553,723 | 659,465 (Direct) | View |
| 2019-11-11 Sale | 2019-11-13 4:31 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 43,000 | $80.59 | $3,465,392 | 809,465 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 4:31 pm | N/A 2034-05-30 | PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director | 62,558 | $0 | 62,558 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 5:33 pm | N/A N/A | Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director | 20,374 | $0 | 46,330 (Direct) | View |
| 2023-06-29 Option Award | 2023-07-03 09:15 am | N/A 2033-06-29 | PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director | 48,128 | $0 | 48,128 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 5:10 pm | N/A N/A | Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director | 18,649 | $0 | 25,956 (Direct) | View |
| 2022-07-11 Option Award | 2022-07-13 9:27 pm | N/A N/A | PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director | 3,028,652 | $0 | 3,028,652 (Direct) | View |
Ownership | 2022-07-13 9:13 pm | N/A N/A | PROKIDNEY CORP. | PROK | DOYLE WILLIAM F Director | 0 | $0 | 0 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-28 7:35 pm | N/A 2032-06-09 | Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director | 2,500 | $0 | 2,500 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:21 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 14,581 | $80.59 | 14,581 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:11 pm | N/A N/A | Elanco Animal Health Inc | ELAN | DOYLE WILLIAM F Director | 7,307 | $0 | 7,307 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 5:49 pm | N/A 2031-06-10 | Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-02 4:14 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 9,259 | $125.25 | 650,393 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-02 4:14 pm | 2019-03-31 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 9,259 | $0 | 650,393 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:57 pm | N/A 2030-06-10 | Minerva Neurosciences Inc. | NERV | DOYLE WILLIAM F Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 07:53 am | N/A 2030-06-09 | OptiNose Inc. | OPTN | DOYLE WILLIAM F Director | 14,439 | $5.65 | 14,439 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-11 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,768 | $64.77 | 740,057 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-11 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,767 | $63.84 | 740,057 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-11 4:17 pm | 2020-05-07 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 117,535 | $0 | 740,057 (Direct) | View |
| 2020-05-05 Exercise | 2020-05-07 4:41 pm | 2020-05-06 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 117,536 | $0 | 920,489 (Direct) | View |
| 2020-05-05 Exercise | 2020-05-07 4:41 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,768 | $61.4 | 920,489 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-07 4:41 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,768 | $64.15 | 920,489 (Direct) | View |
| 2020-05-04 Exercise | 2020-05-06 5:52 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,768 | $60.48 | 804,350 (Direct) | View |
| 2020-05-04 Exercise | 2020-05-06 5:52 pm | 2020-05-04 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 58,768 | $0 | 804,350 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:13 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 9,259 | $79.45 | 524,090 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:13 pm | 2019-02-27 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 9,259 | $0 | 524,090 (Direct) | View |